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The Editorial on the Research Topic
Gut Health: The New Paradigm in Animal Production
Optimal gut health is of vital importance to the performance of production animals. Gut health is 
synonymous in animal production industries with animal health. Although there does appear to be 
a direct relationship between animal performance and a “healthy” gastrointestinal tract (GIT), there 
is no clear definition for “gut health” that encompasses a number of physiological and functional fea-
tures, including nutrient digestion and absorption, host metabolism and energy generation, a stable 
microbiome, mucus layer development, barrier function, and mucosal immune responses (1–8). 
The GIT is responsible for regulating physiological homeostasis that provides the host the ability to 
withstand infectious and non-infectious stressors (9–19). Understanding the interactions between 
these diverse physiological features emphasizes the extent of areas encompassed by gut health and 
the ability to regulate animal production. For our part, we will define gut health as the absence/
prevention/avoidance of disease so that the animal is able to perform its physiological functions in 
order to withstand exogenous and endogenous stressors. Furthermore, worldwide public concerns 
about the production animal industries’ dependency on the use of growth-promoting antibiotics 
(AGPs) have resulted in the ban of AGPs by the European Union and a reassessment of their use in 
the United States. Thus, current research is focused on alternatives to antibiotics for sustainable food 
animal production (20).
A recent Research Topic in Frontiers in Veterinary Infectious Diseases was on gut health and 
wondering whether we should consider gut health as the new standard when considering animal 
production. The objective of this Editorial is not to review the literature on gut health in production 
animals, but, rather, it is our attempt to summarize findings of the 15 papers that were published 
within this Research Topic. Obviously, the Topic was not comprehensive in the production animal 
commodity reported, but it was a very good overview of the current status of the ongoing work in 
gut health and physiology within the veterinary community.
GUt MiCroBioME
The complex gut microbiome is not a silent organ or a collection of passenger microorganisms; but 
rather, the intestinal microbial community represents active participants in vertebrate immunity 
and physiology. The gut microbiota confers health benefits to the host, including aiding in the 
digestion and absorption of nutrients, contributing to the construction of the intestinal epithelial 
barrier, the development and function of the host immune system, and competing with pathogenic 
microbes to prevent their harmful propagation (18, 21). Unlike the host genome, which is rarely 
manipulated by xenobiotic intervention, the microbiome is readily changeable by diet, ingestion of 
antibiotics, infection by pathogens, and other life events [Danzeisen et al.; Ballou et al.; Mon et al.; 
Malmuthauge et al.; (8)].
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Antibiotics have a great effect on the host normal microbiota 
upsetting the balance and inducing a dysbiotic state (8). The use 
of sub-therapeutic doses of antibiotics in animal diets have been 
a common practice for promoting growth due to their ability to 
increase feed efficiency or preventing diseases. Danzeisen et al. 
used a sub-therapeutic concentration of penicillin to define 
beneficial members of the microbiome in turkeys that resulted 
in increased feed efficiency and enhanced growth. By identifying 
the specific bacterial populations responsible for improved per-
formance, the authors hypothesize that these bacteria can then 
be used as probiotics.
The microbiome has a direct effect on the development and 
function of the mucosal immune system. Malmuthauge et  al. 
found significant associations between the microbiome and 
the expression of genes regulating the mucosal barrier and 
innate immunity in neonatal cattle. Regional differences in the 
microbiome were associated with regional differences in innate 
immune gene transcription. Similar findings were described 
between the microbiome of broiler chickens and the expression of 
avian cytokine RNA transcripts (Oakley and Kogut). A negative 
correlation between pro-inflammatory cytokine genes and the 
phylum Firmicutes was found; whereas a positive correlation was 
identified with the pro-inflammatory cytokines and the phylum 
Proteobacteria.
Wigley and Ballou et al. asked the questions: what constitutes 
a normal or healthy microbiome and what effects do treatments 
that are being used to improve gut health (vaccines and probiotics) 
have on the development of the gut microbiome? Wigley pointed 
out that certain bacteria, such as Escherichia coli, Clostridium per-
fringens, and Campylobacter, are often considered commensals 
and part of the cecal microbiome. The removal of AGPs, manipu-
lation of the cecal microbiome, changing husbandry practices, 
and other internal and external factors lead to changes in the host 
responses that result in “new” infections (22–25). Using a live 
attenuated Salmonella vaccine or a lactic acid bacteria probiotic, 
Ballou et  al. characterized the effects of gut health treatments 
have on the microbiome. Alterations in microbial diversity in 
the microbiome of young chicks given the vaccine and, to a less 
extent with the probiotic, were found, which were independent 
of bacterial colonization by the treatments. The microbiome 
alterations were maintained through 28 days of age, suggesting 
that early exposure to certain bacteria may permanently influence 
the microbial diversity in the microbiomes. Similar results were 
described by Mon et al. where a Salmonella infection in day-old 
chicks induced a profound decrease in microbial diversity in the 
cecum. Specifically, there was an increase in Enterobacteriaceae and 
a decrease in butyrate-producing bacteria in the Lachnospiraceae 
family implying that exposure to a Salmonella infection early after 
hatch can impact the composition of the developing microbiome 
that affects colonization resistance to microbial pathogens.
Yeast-derived dietary supplements are increasingly being 
used as pre- and probiotics to improve gut health (26). Roto et al. 
detailed the effects of yeast-derived compounds in livestock diets 
and their effect of the microbiome. The use of yeast-derived com-
pounds as supplements in livestock diets improved performance, 
increased beneficial bacteria in the microbiome, and increased 
immune responsiveness. Additionally, the yeast-derived products 
are cost-effective, do not induce antimicrobial resistance in 
pathogens, and, because of their multiple mechanisms of action, 
can be used in the variety of environments found in livestock 
industries.
MUCoSal iMMUNE rESPoNSE
The intestinal tract is an active immunological organ with more 
resident immune cells than anywhere else in the body. They are 
organized in lymphoid structures called Peyer’s patches and iso-
lated lymphoid follicles, such as the cecal tonsils. Macrophages, 
dendritic cells, various subsets of T cells, B cells, and secretory 
IgA all contribute to the generation of a proper immune response 
to invading pathogens, while keeping the resident microbial 
community in check without generating an overt inflammatory 
response.
In addition to the immune cells, the intestinal epithelial cells 
contribute to mucosal immunity (21). A single layer of epithe-
lial cells separates the densely colonized and environmentally 
exposed intestinal lumen from the sterile subepithelial tissue, 
maintains homeostasis in the presence of the enteric microbiota, 
and contributes to rapid and efficient antimicrobial host defense 
in the event of infection with pathogens. Both epithelial antimi-
crobial host defense and homeostasis rely on signaling pathways 
induced by innate immune receptors demonstrating the active 
role of epithelial cells in the host–microbial interplay. Lastly, 
a layer of mucus overlying the intestinal epithelium forms a 
physical barrier between the mucosa and the resident microbiota, 
minimizing both microbial translocation and excessive immune 
activation by the resident microbes.
Intestinal integrity is fundamentally important for the growth 
and performance of food animals. One of the main advantages 
of AGPs in animal feed was the reduction in the low-grade, 
food-induced chronic inflammation that would otherwise be 
detrimental to animal growth (27). Removal of AGPs from ani-
mal feeds results in an increase in enteric disorders, infections, 
and diseases (24, 25, 28, 29). One of the issues with determining 
dysfunction of the gut barrier is the lack of specific biomarkers. 
Two papers in the Research Topic described new methods that: 
(a) identify serum and tissue biomarkers of gut barrier function 
(Chen et al.) and (b) identify a non-invasive means to measure 
gut inflammation as a marker of gut leakage (Kuttappan et al.). 
Additionally, Ayoola et al. found that the addition of supplemental 
enzymes (β-mannanase, a blend of xylanase, amylase, protease) 
to the diet of turkeys reduced food-induced inflammation.
One of the main immune functions of the epithelial cell sur-
face is the production of antimicrobial peptides or host defense 
peptides [HDPs; Ref. (30)]. HDPs are a diverse group of small 
molecules that possess antimicrobial, immunomodulatory, and 
barrier function enhancing activities. Robinson et al. described 
several classes of small-molecule compounds that induce specific 
induction of endogenous HDP. Furthermore, supplementation of 
these HDP-inducing compounds enhanced bacterial clearance, 
improved enteric barrier integrity, and improved animal produc-
tion efficiency with minimal intestinal inflammation.
The host/pathogen interactome leads to a number of 
immune and biochemical changes at the infection site as the 
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pathogen tries to derive nutrients from the host, while the host 
uses immunometabolic countermeasures against the pathogen. 
Arsenault and Kogut developed a novel tool that characterizes 
the immunometabolic phenotype of infected cells/tissues. The 
kinome peptide array identifies alterations in phosphorylation 
events in both immunity and metabolism simultaneously. The 
kinome array was used to identify the immune changes occurring 
in the cecum of chickens during the establishment of a persis-
tent, asymptomatic Salmonella infection (Kogut and Arsenault). 
A number of immune signaling pathways were activated at the 
site of infection that indicates the development of a tolerogenic 
response allowing the bacteria to establish a persistent infection.
dirECt FEd MiCroBialS
The increased use of grains as alternative energy sources in poul-
try diets has led to an issue with higher levels of less digestible 
carbohydrates that result in an increase in digesta viscosity and 
food-induced inflammation. One alternative to optimize digest-
ibility of these complex carbohydrates is the inclusion of dietary 
enzyme supplements. Latorre et  al. took this concept a step 
further and described the selection of a Bacillus spp. direct fed 
microbial (DFM) candidate based on their capacity to produce 
enzymes that breakdown these complex carbohydrates. Bacillus 
spp. that produced cellulose and xylanase were used as DFM and 
were found to reduce digesta viscosity and reduce C. perfringens 
growth in a number of different diets containing different com-
plex carbohydrates.
A group of natural products known as phytobiotics have been 
the focus of several studies in recent years as antibiotic alterna-
tives (31). Phytobiotics are plant-derived products used in feed 
that possess antimicrobial activity, provide antioxidative effects, 
enhance palatability, improve gut functions, and promote growth. 
Murugesan et al. compared the effects of a commercial phytogenic 
feed additive on growth, intestinal morphology, and microbial 
composition in chickens to the effects of an AGP. Improved 
growth, increased intestinal villus height, and decreased total 
cecal numbers of Clostridium and anaerobic bacteria were 
comparable between the two treatments. However, birds fed the 
phytobiotic additives had a significant reduction in coliforms and 
an increase in Lactobacillus spp. implying an environment that 
was more suitable for the establishment of growth-promoting 
bacteria in the microbiome.
Although the GIT is frequently described simply as ‘‘the gut,’’ it 
is actually made up of (1) an epithelium; (2) a diverse and robust 
immune arm, which contains most of the immune cells in the 
body; and (3) the commensal bacteria, which contain more cells 
than are present in the entire host organism. Understanding of 
the crosstalk between ALL of these interrelated components of 
the gut is what cumulatively makes the gut the basis for the health 
of animals and the motor that drives their performance.
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